Overview

A Phase IV Study of Huazhi Rougan Granule

Status:
Completed

Trial end date:
2018-11-08

Target enrollment:

Participant gender:

Summary

A Placebo control, Randomized, Double-blind, Multicenter Phase IV study to investigate the efficacy and safety of Huazhi Rougan granule in the treatment of non-alcoholic simple fatty liver (damp-heat obstruction syndrome: Shi-Re-Zhong-Zu Zheng)

Phase:

Phase 4

Details

Lead Sponsor:

Shandong New Time Pharmaceutical Co., LTD